Loading…
Loading…
DXCM · NASDAQ · Healthcare
“With no dividend yield and a P/E exceeding 31, this medical device company offers little margin of safety despite its growth prospects in diabetes monitoring.”
— In the voice of Graham
Analyze dividend yield, payout ratio, growth history, and sustainability for income-oriented investment decisions.
Market Cap
$26.39B
P/E Ratio
31.55
Forward P/E
—
EPS
$2.14
PEG Ratio
0.39
Book Value
$7.04
Dividend Yield
—
Profit Margin
17.94%
ROE
30.46%
Use the interactive dividend analyzer with pre-loaded data for Dexcom Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for DXCM: